Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Conformis, Inc. (CFMS) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 2 Buy, 3 Hold, 1 Sell.

CFMS Analyst Ratings

Hold
6
Ratings
2 Buy
3 Hold
1 Sell
Based on 6 analysts giving stock ratings to Conformis, Inc. in the past 3 months
Rating breakdown
Buy
2 33%
Hold
3 50%
Sell
1 17%
33%
Buy
2 analysts
50%
Hold
3 analysts
17%
Sell
1 analysts

People Also View

AORT
AORT
Artivion, Inc.
$37.95
-1.61%
 AXGN
AXGN
AxoGen, Inc.
$34.46
+2.96%
 AVNS
AVNS
Avanos Medical, Inc.
$24.63
+69.51%
 NPCE
NPCE
NeuroPace, Inc.
$15.35
+3.16%
 OFIX
OFIX
Orthofix Medical Inc.
$12.72
+0.55%
 KIDS
KIDS
OrthoPediatrics Corp.
$17.86
+5.37%
 ANIK
ANIK
Anika Therapeutics, Inc.
$15.30
+2.75%
 SGHT
SGHT
Sight Sciences, Inc.
$3.82
+3.52%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message